United States · FDA National Drug Code directory
Levocetirizine Dihydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49035-492_faf3eee1-908d-7d25-bfaf-14c26daabcf7
- Product NDC
- 49035-492
- Form
- TABLET, COATED
- Composition / generic term
- Levocetirizine Dihydrochloride
- Labeler
- Walmart Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190726
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (49035-492-10) / 10 TABLET, COATED in 1 BOTTLE · 49035-492-10
- 1 BOTTLE in 1 CARTON (49035-492-12) / 120 TABLET, COATED in 1 BOTTLE · 49035-492-12
- 1 BOTTLE in 1 BOTTLE (49035-492-35) / 35 TABLET, COATED in 1 BOTTLE · 49035-492-35
- 2 BLISTER PACK in 1 BLISTER PACK (49035-492-79) / 5 TABLET, COATED in 1 BLISTER PACK · 49035-492-79
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →